Most cited papers in Cerebrovascular and genetic disorders
What are the most cited papers in Cerebrovascular and genetic disorders?
The most cited paper in Cerebrovascular and genetic disorders is "Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration" (Joanna Marguerite Wardlaw et al., 2013), with 5,550 citations. Next come "Vascular dementia" (4,937) and "Mild cognitive impairment" (3,903).
Showing 50 of 100 papers. Every paper with more than 450 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration Joanna Marguerite Wardlaw et al. · The Lancet Neurology | 15 Jul 2013 | 5,550 |
| 2 | Vascular dementia Gustavo C. Román et al. · Neurology | Feb 1993 | 4,937 |
| 3 | Mild cognitive impairment Serge G. Gauthier, Barry Reisberg, Michael Zaudig et al. · The Lancet | Apr 2006 | 3,903 |
| 4 | Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges Leonardo Pantoni · The Lancet Neurology | 17 Jun 2010 | 3,452 |
| 5 | Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma Josep O. Dalmau, Erdem Tüzün, Haiyan Wu et al. · Annals of Neurology | 2007 | 2,506 |
| 6 | Migraine prevalence, disease burden, and the need for preventive therapy Richard B. Lipton, MARCELO EDUARDO BIGAL, Merle L. Diamond et al. · Neurology | 30 Jan 2007 | 2,375 |
| 7 | Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II Richard B. Lipton, Walter F. Stewart, Seymour Diamond et al. · Headache The Journal of Head and Face Pain | 12 Jul 2001 | 2,285 |
| 8 | Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia Anne Joutel, Christophe Corpechot, Anne Ducros et al. · Nature | Oct 1996 | 2,086 |
| 9 | The Pathobiology of Vascular Dementia Costantino Iadecola · Neuron | Nov 2013 | 1,882 |
| 10 | Small vessel disease: mechanisms and clinical implications Joanna Marguerite Wardlaw, Colin Smith, Martin Dichgans · The Lancet Neurology | 13 May 2019 | 1,803 |
| 11 | Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging Joanna Marguerite Wardlaw, Colin Smith, Martin Dichgans · The Lancet Neurology | 18 Apr 2013 | 1,693 |
| 12 | Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain Eric H. Schroeter, Jeffrey A. Kisslinger, Raphael Kopan · Nature | May 1998 | 1,645 |
| 13 | Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report Peter T. Nelson et al. · Brain | 22 Mar 2019 | 1,619 |
| 14 | Mild Cognitive Impairment Ronald Carl Petersen · New England Journal of Medicine | 8 Jun 2011 | 1,304 |
| 15 | Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors Raj N. Kalaria, Gladys E. Maestre, Raúl L. Arizaga et al. · The Lancet Neurology | 29 Jul 2008 | 1,240 |
| 16 | Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers Helena Chang Chui, J Victoroff, David Ira Margolin et al. · Neurology | Mar 1992 | 1,207 |
| 17 | Vascular cognitive impairment John Tiernan O'Brien, Timo Erkinjuntti, Barry Reisberg et al. · The Lancet Neurology | 21 Jan 2003 | 1,140 |
| 18 | Vascular dementia John Tiernan O'Brien, Alan J. Thomas · The Lancet | Oct 2015 | 1,135 |
| 19 | A Novel Proteolytic Cleavage Involved in Notch Signaling Christel Brou, Frédérique Logeat, Neetu Gupta et al. · Molecular Cell | Feb 2000 | 1,104 |
| 20 | CADASIL Hugues Chabriat, Anne Joutel, Martin Dichgans et al. · The Lancet Neurology | 17 Jun 2009 | 1,094 |
| 21 | Subcortical ischaemic vascular dementia Gustavo C. Román, Timo Erkinjuntti, Anders Wallin et al. · The Lancet Neurology | 21 Oct 2002 | 1,074 |
| 22 | Notch signaling is essential for vascular morphogenesis in mice Luke T. Krebs, Yingzi Xue, Christine R. Norton et al. · Genes & Development | Jun 2000 | 1,069 |
| 23 | Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria Katherine A. Knudsen, Jonathan M. Rosand, Diane Karluk et al. · Neurology | 27 Feb 2001 | 1,022 |
| 24 | Migraine as a Risk Factor for Subclinical Brain Lesions Mark C. Kruit · JAMA | 27 Jan 2004 | 1,004 |
| 25 | Primary progressive aphasia M.‐Marsel Mesulam · Annals of Neurology | Apr 2001 | 1,003 |
| 26 | MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Troels Staehelin Jensen · PubMed | 25 May 1991 | 996 |
| 27 | The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions Hiroyuki Takahashi, Masabumi Shibuya · Clinical Science | 24 Aug 2005 | 959 |
| 28 | Lacunes C. Miller Fisher · Neurology | Aug 1965 | 923 |
| 29 | Burden of Migraine in the United States Xiaohan Hu, Leona E. Markson, Richard B. Lipton et al. · Archives of Internal Medicine | 26 Apr 1999 | 919 |
| 30 | EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force Stefan Evers, Judit Áfra, Achim Frese et al. · European Journal of Neurology | 7 Aug 2009 | 899 |
| 31 | Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre Jon B. Toledo, Steven Edward Arnold, Kevin M. Raible et al. · Brain | 10 Jul 2013 | 878 |
| 32 | Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine Martin Dichgans, Tobias M. Freilinger, Gertrud Eckstein et al. · The Lancet | 29 Jun 2005 | 859 |
| 33 | Diagnostic Criteria for Vascular Cognitive Disorders Perminder Singh Sachdev, Raj N. Kalaria, John Tiernan O'Brien et al. · Alzheimer Disease & Associated Disorders | 14 Mar 2014 | 831 |
| 34 | Fremanezumab for the Preventive Treatment of Chronic Migraine Stephen David Silberstein, David W. Dodick, MARCELO EDUARDO BIGAL et al. · New England Journal of Medicine | 24 Nov 2017 | 824 |
| 35 | Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2 Miikka Vikkula, Laurence Myriam Boon, Kermit L. Carraway et al. · Cell | Dec 1996 | 812 |
| 36 | Semantic dementia: a unique clinicopathological syndrome John R. Hodges, Karalyn E. Patterson · The Lancet Neurology | Nov 2007 | 795 |
| 37 | Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations Alida A. Gouw, Alexandra Seewann, Wiesje M. van der Flier et al. · Journal of Neurology Neurosurgery & Psychiatry | 9 Oct 2010 | 785 |
| 38 | Extracellular control of TGFβ signalling in vascular development and disease Peter ten Dijke, Helen M. Arthur · Nature Reviews Molecular Cell Biology | 26 Sep 2007 | 776 |
| 39 | Guidelines for Acromegaly Management: An Update Shlomo K. Melmed, Annamaria Colao, Ariel L. Barkan et al. · The Journal of Clinical Endocrinology & Metabolism | 10 Feb 2009 | 764 |
| 40 | Impact of multiple pathologies on the threshold for clinically overt dementia Alifiya Kapasi, Charles S DeCarli, Julie A. Schneider · Acta Neuropathologica | 9 May 2017 | 763 |
| 41 | A genome-wide association study identifies RNF213 as the first Moyamoya disease gene Fumiaki Kamada, Yoko Aoki, Ayumi Narisawa et al. · Journal of Human Genetics | 4 Nov 2010 | 762 |
| 42 | Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated John L. Robinson et al. · Brain | 15 May 2018 | 761 |
| 43 | The overlap between vascular disease and Alzheimer’s disease - lessons from pathology Johannes Attems, K. A. Jellinger · BMC Medicine | 10 Nov 2014 | 748 |
| 44 | The phenotypic spectrum of CADASIL: Clinical findings in 102 cases Martin Dichgans, Michael F. Mayer, Ingo Uttner et al. · Annals of Neurology | Nov 1998 | 736 |
| 45 | Migraine Diagnosis and Treatment: Results From the American Migraine Study II Richard B. Lipton, Seymour Diamond, Michael L. Reed et al. · Headache The Journal of Head and Face Pain | 12 Jul 2001 | 733 |
| 46 | Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development Wanyang Liu et al. · PLoS ONE | 20 Jul 2011 | 729 |
| 47 | Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808 David T. Chien, Anna Katrin Szardenings, Shadfar Bahri et al. · Journal of Alzheimer s Disease | 29 Oct 2013 | 690 |
| 48 | Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients Anne Joutel, Katayoun Vahedi, Christophe Corpechot et al. · The Lancet | Nov 1997 | 687 |
| 49 | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12 Elisabeth Tournier‐Lasserve, Anne Joutel, Judith Melki et al. · Nature Genetics | Mar 1993 | 683 |
| 50 | Clinical spectrum of CADASIL: a study of 7 families Hugues Chabriat, Katayoun Vahedi, M G Bousser et al. · The Lancet | Oct 1995 | 674 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.